Investors

We are a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and branded injectable and inhalation products. We currently manufacture and sell 15 products in the U.S. and are developing a portfolio of 13 generic and 7 branded injectable and inhalation products that primarily target markets with high technical barriers to entry.

More

Copyright Nasdaq. Minimum 15 minutes delayed.

THIS CONFERENCE CALL MAY CONTAIN FORWARD-LOOKING STATEMENTS INCLUDING STATEMENTS RELATING TO AMPHASTAR PHARMACEUTICALS. THESE STATEMENTS ARE NOT HISTORICAL FACTS, BUT RATHER BASED ON AMPHASTAR PHARMACEUTICAL'S CURRENT EXPECTATIONS, ESTIMATES AND PROJECTIONS REGARDING AMPHASTAR PHARMACEUTICAL'S BUSINESS, OPERATIONS AND OTHER SIMILAR OR RELATED FACTORS. WORDS SUCH AS MAY, WILL, COULD, WOULD, SHOULD, ANTICIPATE, PREDICT, POTENTIAL, CONTINUE, EXPECTS, INTENDS, PLANS, PROJECTS, BELIEVES, ESTIMATES AND OTHER SIMILAR OR RELATED EXPRESSIONS ARE USED TO IDENTIFY THESE FORWARD-LOOKING STATEMENTS. THESE STATEMENTS ARE ONLY PREDICTIONS AND ARE SUCH ARE NOT GUARANTEES OF FUTURE PERFORMANCE. AND THEY INVOLVE RISKS, UNCERTAINTIES AND ASSUMPTIONS THAT ARE DIFFICULT OR IMPOSSIBLE TO PREDICT. ACTUAL RESULTS MAY DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS. AS A RESULT OF A NUMBER OF FACTORS INCLUDING THESE DESCRIBED FROM TIME TO TIME AND AMPHASTAR PHARMACEUTICALS' FILINGS WITH THE SEC.*

Privacy Terms & Conditions

This site is intended for residents of the United States

Investors

Press Releases

Events & Presentations